ALOG Stock UPDATES Analogic Corp (ALOG) 72.25 09/12/2014 04:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Analogic Corp (ALOG) 72.25 $ALOG

12.9% Return Seen to Date on SmarTrend Analogic Call (ALOG)
Comtex SmarTrend(R) - Thu Sep 11, 9:52AM CDT
SmarTrend identified a Downtrend for Analogic (NASDAQ:ALOG) on March 7th, 2014 at $82.61. In approximately 6 months, Analogic has returned 12.93% as of today's recent price of $71.93.

Analogic Launches Powerful New Ultrasound System Delivering Three Times the Imaging Information
GlobeNewswire - Wed Sep 10, 10:07AM CDT
Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, today announced the launch of its new bk3000(TM) ultrasound system, the newest addition to its industry-leading family of ultrasound products. The bk3000 is based on Analogic's new TriCore(TM) architecture, which provides Ultra High Resolution imaging and Doppler; accelerated system control; and advanced transducer technology with Twin Cam pinless ZIF (zero insertion force) connectors. The new ultrasound system is targeted for general imaging and urology and procedure guidance applications, and is commercially available in key markets worldwide.

Analogic Showcases Breakthrough Sonic Window Handheld Ultrasound System at AVA's Annual Scientific Meeting
Thomson Reuters ONE - Mon Sep 08, 4:03PM CDT
Ultra-Compact Device for Image-Guided Peripheral Intravenous Access Fits in Coat Pocket

Analogic Down 12.6% Since SmarTrend Downtrend Call (ALOG)
Comtex SmarTrend(R) - Wed Sep 03, 5:28PM CDT
SmarTrend identified a Downtrend for Analogic (NASDAQ:ALOG) on March 7th, 2014 at $82.61. In approximately 6 months, Analogic has returned 12.57% as of today's recent price of $72.23.

B. Braun To Sponsor Workshop and Platinum Showcase at AVA
PR Newswire - Wed Sep 03, 11:09AM CDT
B. Braun Medical Inc. (B.Braun) will exhibit and host a Pre-Meeting Workshop and Platinum Showcase presentation at the 28th Association for Vascular Access (AVA) Annual Scientific Meeting in National Harbor, Maryland, September 7th-10th.

Voce Capital: Questions for CONMED'S Curt Hartman
Business Wire - Wed Sep 03, 7:01AM CDT
Voce Capital Management LLC ("Voce" , which is seeking to elect three independent directors to the Board of CONMED Corporation ("ConMed" or the "Company" (Nasdaq:CNMD) at the Company's delayed annual meeting on September 10, 2014, today poses a number of important questions to Curt Hartman, ConMed's "interim" CEO:

Analogic Announces Timing for Fourth Quarter and End of Fiscal Year 2014 Earnings Conference Call and Webcast
GlobeNewswire - Tue Aug 26, 10:00AM CDT
Analogic Corporation (Nasdaq:ALOG) announced today that it will conduct a conference call on Monday, September 15, 2014, at 5:00 p.m. (ET) to discuss results for the fourth quarter and fiscal year ended July 31, 2014. The conference call will include presentations by Jim Green, president and CEO, and Michael Levitz, senior vice president and CFO. During the call, management will discuss the financial results for the quarter and fiscal year end as well as the outlook for fiscal 2015, and conclude with a question-and-answer session.

Voce Capital: ConMed Board Refuses Voce Offer to Settle Proxy Contest
Business Wire - Tue Aug 26, 8:05AM CDT
--Board Misrepresents the Facts About its Faux Attempts to "Negotiate" with Voce

Voce Capital Responds to ConMed Board's "Plan" to Create Value
Business Wire - Tue Aug 19, 10:20AM CDT
Voce Capital Management LLC ("Voce" responds today to the revelation by the Board of Directors of CONMED Corporation ("ConMed" or the "Company" (Nasdaq:CNMD) of a plan to create shareholder value.

Downtrend Call Working As Analogic Stock Falls 13.6% (ALOG)
Comtex SmarTrend(R) - Mon Aug 18, 4:44PM CDT
SmarTrend identified a Downtrend for Analogic (NASDAQ:ALOG) on March 7th, 2014 at $82.61. In approximately 5 months, Analogic has returned 13.59% as of today's recent price of $71.38.

Voce Capital Files Definitive CONMED Proxy Materials
Business Wire - Thu Aug 14, 11:38AM CDT
--Voce Mails Detailed Update Letter to Fellow Shareholders

Analogic Has Returned 12.1% Since SmarTrend Recommendation (ALOG)
Comtex SmarTrend(R) - Mon Jul 28, 9:30AM CDT
SmarTrend identified a Downtrend for Analogic (NASDAQ:ALOG) on March 7th, 2014 at $82.61. In approximately 5 months, Analogic has returned 12.09% as of today's recent price of $72.62.

Medical Ultrasound Equipment: Radiology, Cardiology, Obstetrics/Gynecology, Vascular, and Others - Global Strategic Business Report 2014
M2 - Fri Jul 18, 6:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8bxwx5/medical) has announced the addition of the "Medical Ultrasound Equipment - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Medical Ultrasound Equipment in US$ Million by the following End-Use Segments: Radiology, Cardiology, Obstetrics/Gynecology, Vascular, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 34 companies including many key and niche players such as: - Analogic Corporation - Esaote SPA - GE Healthcare - Hitachi Aloka Medical, Ltd. - Hitachi Aloka America Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Technological Innovations 3. Market Trends And Issues 4. Competitive Scenario 5. Application Areas Of Ultrasound An Insight 6. Product Overview 7. Ultrasound Versus Other Imaging Modalities 8. Price And Performance 9. Product Introductions/Innovations 10. Recent Industry Activity 11. Focus On Select Players 12. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East & Africa 7. Latin America IV. Competitive Landscape Total Companies Profiled: 34 (including Divisions/Subsidiaries 50) - The United States (23) - Japan (7) - Europe (12) - France (4) - Germany (2) - The United Kingdom (1) - Italy (1) - Spain (1) - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (8) For more information visit http://www.researchandmarkets.com/research/8bxwx5/medical

Corporate Updates, Certifications, and Product Launches - Analyst Notes on Analogic, Masimo, Dr. Reddy's, BioSpecifics and Bio-Rad
PR Newswire - Wed Jul 02, 5:00AM CDT
Today, Analysts Review released its analysts' notes regarding Analogic Corporation (NASDAQ: ALOG), Masimo Corporation (NASDAQ: MASI), Dr. Reddy's Laboratories Limited (NYSE: RDY), BioSpecifics Technologies Corp. (NASDAQ: BSTC) and Bio-Rad Laboratories, Inc. (NYSE: BIO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4358-100free.

Analogic Pays Tribute to Board Member Kevin Melia
GlobeNewswire - Fri Jun 20, 9:15AM CDT
Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, regrets to announce the passing of Kevin Melia, Analogic Director. Mr. Melia passed away on June 17, 2014, after battling a brief illness.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

WIN Expands Global Family Support to 124 Countries

Updated Category News Views 55

WIN's Ambitious Global Expansion In the ever-twisting labyrinth of corporate benefits, WIN is stepping up its game. We're talking an expansion that balloons past traditional fertility offerings into a global medley of support services covering every conceivable family and health scenario. It ain’t just about making babies anymore. When you're dealing with 124 countries,...

Continue Reading
Protalix Unveils Promising Gout Therapy Data at ACR 2026

Updated Category News Views 31

A Glimmer of Hope for Gout Sufferers Uncontrolled gout patients may soon see a light at the end of the tunnel. Protalix BioTherapeutics (NYSE American: PLX) just rolled out data at the ACR Convergence 2026, underscoring the potential of their drug candidate, PRX-115. This revelation is a big deal for those grappling with gout that just won't quit, constantly pelted by...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 202

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
EICMA 2026: Groundbreaking Moves in Two-Wheel World

Updated Category News Views 71

Revving Up in Milan: A Record-Breaking EICMA If you're into two-wheelers as much as stocks, EICMA 2026 is where all the action is happening. They opened the door with a bang at Fiera Milano Rho, pulling off their biggest showcase yet. Ten halls packed to the brim, up from nine the previous year, creating buzz across the globe. Showcasing 765 exhibitors and 2,142 brands...

Continue Reading
New Leadership at Reactive Tech: Claudio Facchin Steps In

Updated Category News Views 154

Facchin Joins Reactive Technologies: Power Play or Predictable Move? Let me tell you, the energy sector ain’t for the faint-hearted—especially when you’re talking grid stability. Reactive Technologies just tossed an ace on the table, appointing Claudio Facchin as the new Board Chairman. If you've been around the block, you might recognize Facchin's name from his...

Continue Reading
Leatt Gears Up for Q3 Results Conference Call

Updated Category News Views 106

A good heads-up, folks, isn't just about keeping helmets snug—it’s about knowing when to cash in, especially when Leatt Corporation's got their Q3 results ready to drop. November 12 is the big day, so circle that on your calendars. They're rolling out the numbers before the market even gets its coffee, possibly nudging the ticker, OTCQB:LEAT, in a ripple you’ll want...

Continue Reading
Target Hospitality's Growth and Earnings Analysis Q3 2026

Updated Category News Views 64

Strategic Transformation: A Mixed Bag of Results In the raucous world of high-stakes business, folks, Target Hospitality Corp. (NASDAQ: TH) is making quite the noise. For Q3 2026, they trumpeted a juicy $129.1 million in revenue, which is a solid notch up by 30% from a year before. Yet, like a seasoned trader facing a knife-edge call, they're handling a bittersweet...

Continue Reading
Energenesis Tackles Space Anemia with ATP Boost

Updated Category News Views 47

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 132

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 55

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

Qatar Airways Reveals New Lounge and Terminal at JFK Airport

Updated Category News Views 254

Qatar Airways Expands Presence at JFK Airport Qatar Airways is set to enhance its operations at John F. Kennedy International Airport by moving to the New Terminal One, which promises a first-of-its-kind experience for travelers in the United States. This airline, renowned for its exceptional service, is preparing to introduce a dedicated lounge in 2026, significantly...

Continue Reading
Venture Global Faces Class Action Amid Legal Challenges

Updated Category News Views 227

Venture Global Faces Legal Action Venture Global, Inc. has recently been embroiled in a securities class action lawsuit filed in the Southern District of New York. The lawsuit pertains to all individuals or entities who acquired Venture's securities during its initial public offering around January 2025, seeking to recover damages under federal securities laws. Claims of...

Continue Reading
Join Aclaris Therapeutics' R&D Day on Immuno-Inflammatory Gaps

Updated Category News Views 151

Aclaris Therapeutics R&D Day Focused on Patient Needs Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a biopharmaceutical organization based in Pennsylvania, is set to host its highly anticipated R&D Day. This event is dedicated to exploring the evolving landscape of immuno-inflammatory diseases and the innovative solutions that the company is developing. The R&D Day will take...

Continue Reading
Cloudelligent Achieves Sixth Ranking in Global MSP List

Updated Category News Views 137

Cloudelligent Celebrates Top Ranking in MSP 501 Cloudelligent, a prominent Managed Cloud Services provider, has reached an impressive milestone by being recognized as the sixth-ranked company on Channel Futures' prestigious MSP 501 list for the year. This distinction is not merely a testament to their robust performance; it underscores their relentless commitment to...

Continue Reading
Lithia Motors Sees Earnings Growth, Yet Shares Decline

Updated Category News Views 116

Lithia Motors Reports Strong Financial Performance Why are Lithia Motors, Inc.‘s shares slipping despite a substantial earnings beat and impressive profitability growth? As investors grapple with mixed signals from the company’s latest financial performance, the story behind the numbers holds the key to understanding market reactions. Lithia Motors shares are trading...

Continue Reading